Now showing items 1-1 of 1

    • Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? 

      Gray, Glenda E.; Metch, Barbara.; Churchyard, Gavin J.; Mlisana, Koleka Patience.; Nchabeleng, Maphoshane.; Allen, Mary.; Moodie, Zoe.; Kublin, James.; Bekker, Linda-Gail. (Elsevier., 2013-04-12)
      Background: Increased sexual risk behaviour in participants enrolled in HIV prevention trials has been a concern. The HVTN 503/Phambili study, a phase 2B study of the Merck Ad-5 multiclade HIV vaccine in South Africa, ...